CD Formulation Announces Ability to Test the Contact Angle of Pharmaceutical Excipients for Better Selecting Surfactants

August 19, 2024 04:31 PM AEST | By EIN Presswire
 CD Formulation Announces Ability to Test the Contact Angle of Pharmaceutical Excipients for Better Selecting Surfactants
Image source: EIN Presswire

Earlier this month, CD Formulation has announced its capability to precisely measure the contact angle of pharmaceutical excipients.

NY, UNITED STATES, August 19, 2024 /EINPresswire.com/ -- In a significant leap forward for the pharmaceutical industry, CD Formulation has announced its capability to precisely measure the contact angle of pharmaceutical excipients. This critical advancement is set to aid in the superior selection of surfactants, streamlining drug formulation processes and amplifying efficacy.

The contact angle is a measure of the wettability of a solid surface by a liquid. This measurement is crucial in the realm of pharmaceuticals, where understanding the interaction between excipients and active pharmaceutical ingredients (APIs) is vital for effective drug delivery and stability.

When it comes to surfactants—compounds that lower surface tension between two liquids or a liquid and a solid—the contact angle can indicate how well a surfactant can function. Surfactants play a key role in improving the solubility and bioavailability of APIs. By accurately determining the contact angle, researchers can better predict and enhance the behavior of these crucial compounds during formulation.

Choosing the right surfactant is a nuanced process, often involving trial and error. With CD Formulation's new ability to test contact angles, the industry now has a robust tool for making informed decisions. This method allows for a more scientific approach to formulating drugs, reducing guesswork and potentially lowering the time and cost associated with drug development.

"Accurately measuring the contact angle of pharmaceutical excipients will revolutionize how we select and utilize surfactants in drug formulations. This will ultimately lead to more effective and reliable medications." said Chief Scientist at CD Formulation.

Moreover, the implications of this advancement extend beyond surfactants. Understanding contact angles plays a role in tablet formulation, coating processes, and improving the delivery mechanisms for a wide array of medications. For instance, in tablet coatings, achieving optimal wettability can improve the dissolution rate of a drug, making it more effective for the patient.
In addition, in fields such as inhalation therapies, where moisture and particulates interaction is critical, knowing the precise contact angle can lead to significant improvements in drug delivery systems.

About CD Formulation
CD Formulation's introduction of precise contact angle testing for pharmaceutical excipients marks a monumental step forward in drug formulation science. This breakthrough promises to improve surfactant selection processes, ensuring that new medications are both effective and reliable. As the pharmaceutical landscape continues to evolve, such advancements highlight the importance of integrating cutting-edge technology with traditional pharmaceutical expertise.

Helen Smith
CD Formulation
[email protected]


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.